Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cheers. Finally coming out of the aimless wandering in the desert phase. Next few years should be bright AF, need some shades.
Sad, sad existence!
Thing of beauty.
Lol .0269 - .17 52w range, wild
Zzz the guy that agrees with himself
The 20% gain from yesterday? Yeah it was awful.
Lmao who are these chumps, not even trying anymore. Put some effort into it!!
The funny part is that the CEO just laid out the roadmap for the company’s future growth. They are growing so fast that it’s actually becoming a problem to store all the finished product. Anyone with a pair of functioning eyes can clearly see the improving financials and the handful of billion dollar generic drugs they are formulating for, trialing, and have already filed for.
If people still want to sell off shares in spite of all that, their loss - just scoop up more.
I think he meant Concerta or whatever the 3rd big “needle mover” product we’ll likely file in 2024 after Oxy and Vyvanse.
Looks like replay is up - https://elite.irpass.com/events_presentations
if it hasn’t been posted here yet
Sure you got the right stock?
Same, ready to hear replay.
Geez lol
Poison pill expires as of today or tomorrow, yeah? Don’t have the old filing in front of me.
Not gonna work, clown!
Let’s goooo. So maybe just good ole fashioned FDA foot dragging.
Yup. Nasrat’s planning and Lannett’s push ironically put us in the best position yet.
IF numbers like $14.2M in revenues are a new baseline for Elite, that’s $56.8M annually.
This is also before Burel partnership starts on Jan 1.
Doesn’t mean it can’t open there and dip back down
Open .13, close .19
Thought that was based off the stock price rise?
Haha. Smoked it!!
He also responded to one of my questions and essentially said, more or less: “Our big product opportunities coming up are CNS and Opioids, we don’t have a Cardiovascular product *yet*.”
Thanks James! Hopefully we start seeing a lot more XR sales before long.
Heard that at .03, and .05, and .10, and .12, and .15.
Then we’ll keep hearing more of the same at .20, and .25, and then at .30, .40, .50, on and on.
You’re an absolute joke on this board. Better cover.
Trying to convince yourself now or what
You tried to discourage people from buying ELTP around the .03s and it’s done a 5x in the months since.
Thoughts?
11,250,000
Maybe. That’s an interesting thought.
Elite’s company blurb lately in the PRs is “a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products.” I guess that can apply to a tiny drug market of 1-2 competitors or something like Adderrall, Vyvanse, etc.
Gotta consider too that these products take years(?) to go from formulation development to initial trials to human trials to filing to approval, right? Market size can always change in the interim and the number of competitors is definitely in flux. If the idea for this dopamine agonist was several years old, we were bringing in fewer revenues then. Maybe it was a “let’s keep the lights on, go for the easier singles and doubles” before we tackle the home run-type products? Just speculating.
My guess as well.
Yeah, wondering if it’s just a delay on FDA’s end or if there was actually a CRL. Like Jour said, if CRL, we should know in a couple weeks.
Not a “needle mover” product but still would be nice to stack another piece of good news on the pile.
Don’t worry about him, he’s a clown just like many of the other clowns on this board trying to tell us for years not to believe our “lying eyes.”
Elite is growing and profitable. They’re already expecting to need more facility space. Revenues have gone up for what, 4 years straight? 10 billion in market size we’re about to be playing in? Adderralls on the shortage list and another big partnership starting on Jan 1? Generic Vyvanse about to be filed? Likely a Concerta in trials next? Oxy on file? Kirko squeezing more $$$ out of all our drugs, large and small, by selling them himself?
The clowns used to have somewhat legitimate arguments - they’ll never get approvals, they’ll go bankrupt, yada yada. They don’t anymore. It’s telling how weak they sound now - “uh something doesn’t seem right.” LOL
If there was a hard 15 on the craps table, that’d be the only bet Jammy ever made.
Nice! Always appreciate your relevant pharmacy insight.
Do you happen to see any differences in supply of, or demand for, Vyvanse vs. Concerta vs. Adderralls where you work?
Aye, probably just in the unlucky 10%.
Hopefully we see it on FDA’s site soon and then a PR shortly after.
It’s possible. My guess is just good ole fashioned government delays though.
Nah he/she/it does that all the time, what a clown. Go back and look, I called it ahead of time.
Predictable idiot. Lol
Why’d you reply to yourself for the 2nd time today?
Haha owned